Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Chan

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Hybridoma|January 8, 2000
Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassayT J Wang, H J Linton, J Payne, et al.
The Journal of Urology|November 7, 2001
Plasma selenium level before diagnosis and the risk of prostate cancer developmentJ D Brooks, E J Metter, D W Chan, et al.
Clinical Chemistry|October 1, 1988
Monitoring breast cancer with CA 549D W Chan, R A Beveridge, D J Bruzek, et al.
The Journal of Urology|April 1, 1990
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasiaA W Partin, H B Carter, D W Chan, et al.
The Prostate|July 21, 2004
Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOFM B Gretzer, D W Chan, C L van Rootselaar, et al.
The Journal of Urology|April 1, 1988
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomyJ E Oesterling, D W Chan, J I Epstein, et al.
The Journal of Pathology|May 9, 2008
Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesisD W Chan, S Y M Yu, P M Chiu, et al.
The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.
Clinical Chemistry|November 1, 1983
Clinical evaluation of two direct procedures for free thyroxin, and of free thyroxin index determined nonisotopically and by measuring thyroxin-binding globulinJ M Waud, D W Chan, H M Drew, et al.
Urology|December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancerJ Pannek, H G Rittenhouse, C L Evans, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Hybridoma|January 8, 2000
Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassayT J Wang, H J Linton, J Payne, et al.
The Journal of Urology|November 7, 2001
Plasma selenium level before diagnosis and the risk of prostate cancer developmentJ D Brooks, E J Metter, D W Chan, et al.
Clinical Chemistry|October 1, 1988
Monitoring breast cancer with CA 549D W Chan, R A Beveridge, D J Bruzek, et al.
The Journal of Urology|April 1, 1990
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasiaA W Partin, H B Carter, D W Chan, et al.
The Prostate|July 21, 2004
Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOFM B Gretzer, D W Chan, C L van Rootselaar, et al.
The Journal of Urology|April 1, 1988
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomyJ E Oesterling, D W Chan, J I Epstein, et al.
The Journal of Pathology|May 9, 2008
Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesisD W Chan, S Y M Yu, P M Chiu, et al.
The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.
Clinical Chemistry|November 1, 1983
Clinical evaluation of two direct procedures for free thyroxin, and of free thyroxin index determined nonisotopically and by measuring thyroxin-binding globulinJ M Waud, D W Chan, H M Drew, et al.
Urology|December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancerJ Pannek, H G Rittenhouse, C L Evans, et al.
Pageof 17